Quantcast

Posts related to ‘BMY’

Lipitor OTC: What Next? (PFE, MRK, AZN, SNY, BMY, LLY, JNJ, AMGN)

Once patent protection expires on a prescription drug, the drug's maker can take a serious beating in revenue and profitability. One way to make up for the loss is to ...
Read Full Story »

Beyond the Pharma Patent Cliff, Dividends Galore (LLY, BMY, MRK, PFE, ABT)

Many drug companies face a what is called a patent cliff ahead, where the Big Pharma players will have key drugs go off-patent and there will be new generic competition.  ...
Read Full Story »

Screening the Highest Dividends in Defensive Stocks (MO, RAI, LO, KMB, LLY, HNZ, CAG, TAP, DPS, AWK)

We may have just witnessed an oversold bounce in the stock market, or we may be in for more days of recovery.  The markets are flirting with six weeks of ...
Read Full Story »

Top Analyst Upgrades & Downgrades (AIXG, BMY, DKS, HEV, GNC, HMY, HBAN, HUN, JASO, JNJ, NTAP, NYB, QIHU, SBUX, UTI, WMB)

These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Wednesday morning. Aixtron SE (NASDAQ: AIXG) Cut to Sell at Canaccord Genuity. Bristol-Myers ...
Read Full Story »

BioHealth Watch: Cancer Wars (BMY, DNDN, VICL)

The fight against melanoma just got a new weapon after a drug called Yervoy, or ipilimumab, was given FDA approval for late-stage metastatic melanoma.  The approval is a win for ...
Read Full Story »

The Coming Week’s Must See Stock Events (ANN, VOXX, BEC, BMY, SU, CNQ, DIN, GS, EGPT, ICGE, OTEX, JDSU, KMP, KMR, KV-A, LULU, MU, NDAQ, OREX, QCOR, SIRI)

Earnings season may still be in force, but we are looking for the coming week's top coming events that could have a large impact on shares on Monday and throughout ...
Read Full Story »

Media Digest 11/19/2010 (Reuters, WSJ, NYT, FT, Bloomberg)

Dell's (NASDAQ: DELL) margins rushed past expectations and shares moved higher (Reuters) Bernanke said a strong US recovery is essential to global economic health (Reuters) Lawmakers attacked regulators and banks ...
Read Full Story »

The Rapid Growth Of Layoffs In Pharma, As Industry Despairs Of Its Future

Bristol-Myers Squibb (NYSE: BMY) will cut nearly 1,000 workers. That is on top of large rounds of firings in 2007 and 2008. The company gave an odd reason for the ...
Read Full Story »

Media Digest (9/24/2010) Reuters, WSJ, NYT, FT, Bloomberg

Reuters: Petrobras raised $70 billion in the largest stock offer in history. Reuters:   There will likely be no tax cut before the election, according to Democrats Reuters:   Obama asked the ...
Read Full Story »

Media Digest 9/8/2010 Reuters, WSJ, NYT, FT, Bloomberg

Reuters:   Japan's plan to intervene in yen trading has not moved the currency lower. Reuters:   Oil dropped as investor moved away from risk Reuters:   Hewlett-Packard (NYSE: HPQ) sued to keep ...
Read Full Story »

Top Analyst Upgrades and Downgrades (AEO, BMY, CAGC, CEO, STZ, FO, HL, MHS, WFR, SQNM, X, WAG)

These are some of this Friday's top analyst calls with upgrades, downgrades, and initiations seen in Wall Street research notes: American Eagle Outfitters, Inc. (NYSE: AEO) Raised to Buy at ...
Read Full Story »

BioHealth Business Daily (ARQL, APPY, BPAX, BMY, CLDX, CELG, DCTH, JAV, KERX, PCYC, TLCR, VVUS)

Today's edition of the BioHealth Business Daily is going to be very cancer-dominated due to the American Society of Clinical Oncology (ASCO) 2010 meeting that started this last weekend.  There ...
Read Full Story »

Top Day Trader Alerts (ARQL, BPAX, BMY, BP, CTIC, KRY, TLCR, VVUS)

We have several big movers on news this morning, and none appear to be based upon earnings.  Stocks on the move are ArQule Inc. (NASDAQ: ARQL), BioSante Pharmaceuticals, Inc. (NASDAQ: ...
Read Full Story »

Top Analyst Upgrades and Downgrades (AMZN, ANN, ABT, ATHN, ADSK, EAT, BMY, CELG, CSCO, FSLR, INTU, STP, SPWRA)

These are some of the major research calls we have seen from analysts in their upgrades, downgrades, and initiations so far this Monday: Amazon.com, Inc. (NASDAQ: AMZN) Raised to Conviction ...
Read Full Story »

Big Pharma Makes More Money On Kids, Use Of Medications Among The Young Rises

The pharmaceutical industry has found a growing source of sales--the prescription of medicines, primarily used by adults in the past, to children. A portion of the sharp increase in drugs ...
Read Full Story »